byiShook Opinion
Aug 9, 2024 - 11:25
Avidity unveiled promising results for its DMD treatment on Friday and the top-notch biotech stock catapulted. RNA stock is highly rated. The post How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics appeared first on Investor's Business Daily.
Avidity unveiled promising results for its DMD treatment on Friday and the top-notch biotech stock catapulted. RNA stock is highly rated.
The post How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics appeared first on Investor's Business Daily.